A recent study suggests that optogenetic stimulation of neurons enhances the expression of neuroligin-3 (NLGN3), which, in turn, promotes tumor cell proliferation through the PI3K-mTOR tumor-intrinsic pathway in patient-derived xenograft glioma models. This evidence concerns the gene NLGN3 and central nervous system cancer.